Ming Yan Xu
Vorstandsvorsitzender bei Shenzhen Haplox Biotechnology Co., Ltd.
Profil
Ming Yan Xu is the founder of Shenzhen Haplox Biotechnology Co., Ltd., where they currently hold the title of Chairman & Chief Executive Officer since 2014.
They also founded HaploX Investment Holding Ltd.
in 2021, where they held the title of Chairman & Chief Executive Officer.
Dr. Xu obtained a doctorate degree from The University of New Mexico in 2013 and a graduate degree from Beijing Normal University in 2008.
Aktive Positionen von Ming Yan Xu
| Unternehmen | Position | Beginn |
|---|---|---|
Shenzhen Haplox Biotechnology Co., Ltd.
 Shenzhen Haplox Biotechnology Co., Ltd. BiotechnologyHealth Technology Shenzhen Haplox Biotechnology Co. Ltd. develops clinical application device which helps to detect cancer tumour. The firm’s products cover cancer early screening, individualized drug guidance, prognosis monitoring, drug resistance assessment and provide precision cancer health care for the patients. The company was founded by Shi Fu Chen, Wen Fang, Yuan Wen and Ming Yan Xu on September 12, 2014 and is headquartered in Shenzhen, China. | Vorstandsvorsitzender | 01.08.2014 |
Ehemalige bekannte Positionen von Ming Yan Xu
| Unternehmen | Position | Ende |
|---|---|---|
HaploX Investment Holding Ltd.
 HaploX Investment Holding Ltd. Miscellaneous Commercial ServicesCommercial Services HaploX Investment Holding Ltd. engages in the provision of genetic testing solutions with a focus on using molecular diagnostics technologies. It offers genetic testing results that enable full cycle health management for cancer and other patients as well as health screening and risk assessment for individuals, genetic testing of pathogenic microbes, and other pathogens, to research and development genetic testing primarily for biopharmaceutical companies and research institutes. The company was founded by Ming Yan Xu, Yuan Wen, Shi Fu Chen, and Wen Fang on November 29, 2021 and is headquartered in Hong Kong. | Vorstandsvorsitzender | - |
Ausbildung von Ming Yan Xu
| Beijing Normal University | Graduate Degree |
| The University of New Mexico | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Shenzhen Haplox Biotechnology Co., Ltd.
Shenzhen Haplox Biotechnology Co., Ltd. BiotechnologyHealth Technology Shenzhen Haplox Biotechnology Co. Ltd. develops clinical application device which helps to detect cancer tumour. The firm’s products cover cancer early screening, individualized drug guidance, prognosis monitoring, drug resistance assessment and provide precision cancer health care for the patients. The company was founded by Shi Fu Chen, Wen Fang, Yuan Wen and Ming Yan Xu on September 12, 2014 and is headquartered in Shenzhen, China. | Health Technology |
HaploX Investment Holding Ltd.
HaploX Investment Holding Ltd. Miscellaneous Commercial ServicesCommercial Services HaploX Investment Holding Ltd. engages in the provision of genetic testing solutions with a focus on using molecular diagnostics technologies. It offers genetic testing results that enable full cycle health management for cancer and other patients as well as health screening and risk assessment for individuals, genetic testing of pathogenic microbes, and other pathogens, to research and development genetic testing primarily for biopharmaceutical companies and research institutes. The company was founded by Ming Yan Xu, Yuan Wen, Shi Fu Chen, and Wen Fang on November 29, 2021 and is headquartered in Hong Kong. | Commercial Services |
